Contribution of Cancer-Targeting Drugs toward Faster Clinical Application

Sungpil Yoon; Hyung Sik Kim

doi:10.3390/ijms23126445

Contribution of Cancer-Targeting Drugs toward Faster Clinical Application

Int J Mol Sci. 2022 Jun 9;23(12):6445. doi: 10.3390/ijms23126445.

Authors

Sungpil Yoon¹, Hyung Sik Kim¹

Affiliation

¹ School of Pharmacy, Sungkyunkwan University, 2066 Seobu-ro, Jangan-gu, Suwon 16419, Korea.

Abstract

With advances in cancer-targeting therapeutic strategies, cancer cells have developed drug resistance [...].

Publication types

Editorial

MeSH terms

Antineoplastic Agents* / pharmacology
Antineoplastic Agents* / therapeutic use
Drug Resistance, Neoplasm
Humans
Neoplasms* / drug therapy

Substances

Antineoplastic Agents

Grants and funding

This work was supported by National Research Foundation of Korea (NRF) funded by the Ministry of Education (NRF-2019R1A2C2002923). This research was also supported by the SungKyunKwan University and the BK21 FOUR (Graduate School Innovation) funded by the Ministry of Education (MOE, Korea) and National Research Foundation of Korea (NRF).